The Compliers Group International BV, a Dutch provider of pharma packaging solutions that contain microchips to monitor a patient’s therapy compliance, has raised an undisclosed amount of private equity funding from DSM Venturing, a unit of Royal DSM NV.
DSM Venturing, the corporate venturing unit of Royal DSM N.V., today announces that it has made an equity investment in The Compliers Group International B.V. (TCG). The Netherlands-based company focuses on the development of smart pharmaceutical packaging solutions that contain microchips which enable the monitoring of a patient’s therapy compliance. Financial details of the investment will not be disclosed.
TCG’s smart packaging solutions can be applied in any existing standard medication blister and will record when a pill has been removed from the blister. This information can be read out wirelessly (e.g. with a mobile phone) and made available to caregivers and patients in day-to-day medication therapy or to pharmaceutical companies or research organizations in clinical studies.
The system will help both patients and volunteers taking part in clinical studies to take their pills at the right time. Caregivers and pharmaceutical companies will be able to better diagnose or judge the effectiveness of medication. This can help to substantially reduce healthcare costs.
First proof of concept of TCG’s “Objective therapy Compliance Measurement” (OtCM®) technology has been obtained. TCG also applies its technology in projects with Ministries of Health, health insurers and others, such as research organizations.
The investment is in line with DSM’s ambition to build a leading position in Specialty Packaging, one of the four Emerging Business Areas as defined in its Vision 2010 strategy. DSM’s capabilities in Materials Sciences and Life Sciences enable the company to develop unique innovations for the packaging industries. Next to developing intelligent food packaging systems, DSM Specialty Packaging is also exploring opportunities in the rapidly developing smart packaging market for pharma and nutraceuticals. The cooperation with TCG will facilitate DSM Specialty Packaging’s entrance into the markets where the convergence of the packed products, materials, systems and services is a key factor to deliver functional value to the users. Next to the investment DSM and TCG will work together on the development of new technologies.
Tony de Vrught, Vice President DSM Specialty Packaging says: “Intelligent packaging systems aimed at improving patient adherence could substantially contribute to decreasing overall healthcare costs in the future as they reduce the need for more costly interventions. I see this as a logical step forward in combining our knowledge of Life Sciences and Materials Sciences opening up interesting perspectives in innovative packaging applications. I look forward to working with TCG to develop innovative solutions for this market.”
Jos Geboers and Willem Kort, Founders and Managing Directors of TCG: “This partnership with DSM will help us to refine our product and market development path. Our combined capabilities will accelerate the global implementation of our products, technologies and services as DSM has unique knowledge in both Life Sciences and Materials Sciences.”